Evento cerebro vascular y foramen oval permeable: caso clínico

  • Olga Campoverde Universidad Católica de Cuenca | Cuenca | Ecuador |
  • Francy Hollminn Salas Contreras Universidad Católica de Cuenca | Cuenca | Ecuador
  • Claudia Jazmín Niño Peñaranda Universidad Católica de Cuenca | Cuenca | Ecuador
Palabras clave: Accidente cerebrovascular isquémico; Anatomía cardiaca; Defecto cardiaco congénito; Accidente cerebrovascular criptogénico; Comunicación interauricular.

Resumen

El foramen oval permeable (FOP) es una anomalía cardíaca congénita que afecta aproximadamente al 25% de la población y está enfrentada por accidentes cerebrovasculares isquémicos. Se diagnóstico mediante ecocardiografía transtorácica o transesofágica. Sin embargo, el cierre del FOP no es concluyente y no existe una estrategia de tratamiento claramente definida. Se presenta un caso clínico de enfoque descriptivo y retrospectivo, basado en la revisión de historias clínicas y la recopilación de artículos obtenidos de bases de datos como Scopus, Pubmed y Wiley Online Library. La mujer de 63 años, con antecedentes de fiebre reumática, estenosis mitral e hipertensión pulmonar leve, lleva al hospital por alteración del estado de conciencia. Se le diagnostica un posible accidente cerebrovascular isquémico, el tratamiento anticoagulante se inicia, y la paciente se muestra mejora en el seguimiento postoperatorio, con monitoreo continuo y ajustes en el tratamiento médico.

Descargas

La descarga de datos todavía no está disponible.

##plugins.generic.paperbuzz.metrics##

Cargando métricas ...

Citas

Abdelghani, M., El-Shedoudy, S., & Nassif, M. (2019). Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: An Update. Cardiology, 143(1), 62–72.

Alakbarzade, V., Keteepe, T., & Karsan, N. (2020). Patent foramen ovale. Pract Neurol, 20(3), 225–33.

Buck, H. B., Akhtar, N., & Alrohimi, A. (2021). Stroke mimics: incidence, aetiology, clinical features and treatment. Ann Med, 53(1), 420–36.

Campbell, B., De Silva, D., & Macleod, M. (2019). Ischaemic stroke. Nat Rev Dis Primers, 5(1), 1–22.

Campbell, B., & Khatri, P. (2020). Stroke. Lancet, 396(10244), 129–42.

Chiang, M., Dumitrascu, O., & Chhabra, N. (2021). Migraine with Visual aura and the Risk of Stroke- a Narrative Review. J Stroke Cerebrovasc Dis, 30(11), 1–10.

Connolley, H., & Taggart, N. (2023, 20 de diciembre). Cierre quirúrgico y percutáneo de comunicación interauricular en adultos. UpToDate. https://lc.cx/9U-OPg

Cucchiara, B., & Messe, S. (2023, o8 de marzo). Long-term antithrombotic therapy for the secondary prevention of ischemic stroke. UpToDate. https://lc.cx/aTzl6w

Debette, S., Schilling, S., & Duperron, M. (2019). Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis. JAMA Neurol, 76(1), 81–94.

Diener, H., & Hankey, G. (2020). Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar. J Am Coll Cardiol, 75(15), 04–18.

Edwarson, M. (2023, 07 de febrero). Overview of ischemic stroke prognosis in adults. UpToDate. https://lc.cx/Xl17rM

Evola, S., Camarda, E., & Triolo, O. (2023). Clinical Outcomes and Quality of Life after Patent Foramen Ovale (PFO) Closure in Patients with Stroke/Transient Ischemic Attack of Undetermined Cause and Other PFO-Associated Clinical Conditions: A Single-Center Experience. J Clin Med, 12(18), 1–11.

Flach, C., Muruet, W., & Wolfe, C. (2020). Risk and Secondary Prevention of Stroke Recurrence. Stroke, 51(8), 35–44.

Fortuni, F., Crimi, G., & Leonardi, S. (2018). Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events. Journal of Cardiovascular Medicine, 19(7), 373–81.

Friedrich, S., Ng, P., & Platzbecker, K. (2019). Patent foramen ovale and long-term risk of ischaemic stroke after surgery. Eur Heart J, 40(11), 14–24.

Gonzalez, J., & Testai, F. (2021). Advances and Ongoing Controversies in Patent Foramen Ovale Closure and Cryptogenic Stroke. Neurol Clin, 39(1):51–69.

Gutiérrez, R., Fuentes, B., & Díez, E. (2018). Cryptogenic stroke. A non-diagnosis. Med Clin (Barc), 151(3), 16–22.

Gutiérrez, R., Fuentes, B., & Díez, E. (2019). Ictus isquémico. Infarto cerebral y ataque isquémico transitorio. Medicine–Programa de Formación Médica Continuada Acreditado, 12(70), 85–96.

Ioannidis, S., & Mitsias, P. (2020). Patent foramen ovale in cryptogenic ischemic stroke: Direct cause, risk factor, or incidental finding? Front Neurol, 11(567), 1–6.

Jacob, M., Ekker, M., & Allach, Y. (2022). Global Differences in Risk Factors, Etiology, and Outcome of Ischemic Stroke in Young Adults-A Worldwide Meta-analysis: The GOAL Initiative. Neurology, 98(6), 73–88.

Jauch, E. (2022). Ischemic Stroke: Practice Essentials, Background, Anatomy. Medscape, 1(1), 9–17.

Kamel, H. (2020). The Evolving Concept of Cryptogenic Stroke. Continuum, 26(2), 353–62.

Karenberg, A. (2020). Historic review: select chapters of a history of stroke. Neurol Res Pract, 2(1), 1–11.

Knight, A., Nario, J., & Gupta, A. (2019). Causes of Acute Stroke: A Patterned Approach. Radiol Clin North Am, 57(6), 93–108.

Koutroulou, I., Tsivgoulis, G., & Tsalikakis, D. (2020). Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review. Front Neurol, 11(281), 1–12.

Lio, K., Kumaran, M., & Rali, P. (2019). Patent foramen ovale: Connecting dots from massive pulmonary embolism to acute ischemic stroke. Official Organ of Indian Chest Society, 36(6), 564–566. https://doi.org/10.4103/lungindia.lungindia_276_19

Mañero, C., Durán, P., & Delgado, N. (2021). Foramen oval permeable. Una actualización para atención primaria [Patent foramen ovale. An update for primary care]. Semergen, 47(3), 189–196. https://doi.org/10.1016/j.semerg.2020.12.003

Mazzucco, S., Li, L., & Binney, L. (2018). Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis. Lancet Neurol, 17(7), 09–17.

McClelland, G., Rodgers, H., & Flynn, D. (2019). The frequency, characteristics and aetiology of stroke mimic presentations: a narrative review. Eur J Emerg Med, 26(1), 2–8.

Messe, S., & Brecker, S. (2023, 28 de febrero). Stroke associated with patent foramen ovale (PFO): Evaluation. UpToDate. https://lc.cx/1kRMyd

Mojadidi, M., Kumar, P., & Mahmoud, A. (2021). Pooled Analysis of PFO Occluder Device Trials in Patients With PFO and Migraine. J Am Coll Cardiol, 77(6), 67–76.

Mojadidi, M., Zaman, M., & Elgendy, I. (2018). Cryptogenic Stroke and Patent Foramen Ovale. J Am Coll Cardiol, 71(9), 35–43.

Montoro, L., Ruiz, M., & Delgado, M. (2022). Adecuación del nuevo sistema de clasificación de probabilidad causal de accidente cerebrovascular asociado al foramen oval permeable. Experiencia de un único centro, 75(1), 2–3.

Murphy, S., & Werring, D. (2020). Stroke: causes and clinical features. Medicine, 48(9), 1–6.

Navarro, R., Aliaga, J., & López, M. (2020). Lung recruitment maneuvers: opening the door to a hidden enemy. Rev Esp Anestesiol Reanim, 67(2), 99–102.

Novo, A., Pinzón, P., & Rozas, P. (2022). Ischaemic or transient attack? Magnetic resonance imaging in transient ischaemic attack: a review of 106 cases. Rev Neurol, 75(11), 33-39.

Ohya, Y., Matsuo, R., & Sato, N. (2022). Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study. PLoS One, 17(7), 1–15.

Phipps, M., & Cronin, C. (2020). Management of acute ischemic stroke. BMJ, 368, 1–12.

Powers, W., Rabinstein, A., & Ackerson, T. (2019). Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 50(12), 344–418.

Provost, C., Soudant, M., & Legrand, L. (2019). Magnetic Resonance Imaging or Computed Tomography Before Treatment in Acute Ischemic. Stroke 50(3), 59–64.

Saini, V., Guada, L., & Yavagal, D. (2021). Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions. Neurology, 97(2), 6–16.

Sloane, K., & Camargo, E. (2019). Antithrombotic Management of Ischemic Stroke. Curr Treat Options Cardiovasc Med, 21(11), 1–15.

Teshome, M., Najib, K., & Nwagbara, C. (2020). Patent Foramen Ovale: A Comprehensive Review. Curr Probl Cardiol, 45(2), 1–15.

Tobis. J., Elgendy, A., & Saver, J. (2020). Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale–Associated Stroke. JAMA Neurol, 77(7), 78–86.

Wang, X., Ouyang, M., & Yang, J. (2021). Anticoagulants for acute ischaemic stroke. Cochrane Database of Systematic Reviews, 1(10), 6–22.

Wiktor, D. M., & Carroll, J. (2018). The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke. Circ Cardiovasc Interv, 11(3), 1–12.

Young, C., Bonow, R., & Barros, G. (2019). Magnetic resonance vessel wall imaging in cerebrovascular diseases. Neurosurg Focus, 47(6), 1–8.

Publicado
2024-09-13
Cómo citar
Campoverde, O., Salas Contreras, F. H., & Niño Peñaranda, C. J. (2024). Evento cerebro vascular y foramen oval permeable: caso clínico. Religación, 9(42), e2401294. https://doi.org/10.46652/rgn.v9i42.1294